|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | An evaluation of the potential for pharmacokinetic interaction between escitalopram and the cytochrome P450 3A4 inhibitor ritonavir显示文摘 | Gutierrez M Rosenberg J Abramowitz W | 2003 | Clin Ther2003，25，： | 1 |
| 2 | An evaluation of the potential for pharmacokinetic interaction between escitalopram and the cytochrome P450 3A4 inhibitor ritonavir显示文摘 | GUTIERREZ MM ROSENBERG J ABRAMOWITZ W | 2003 | Clin Ther2003，25，4： | 1 |
| 3 | Lack of effect of a single dose ketoconazole on the pharmacokinetics of citalopram显示文摘 | Gutierrez M Abramowitz W | 2001 | Pharmacotherapy2001，21，2： | 1 |
| 4 | On the crushing mechanism of thin-walled structures 显示文摘 | Wierzbicki T Abramowitz W | 1983 | Journal of Applied Mechanics1983，50，4： | 1 |
| 5 | Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers 显示文摘 | Kapil R Nolting A Roy P Fiske W Benedek I Abramowitz W | 2004 | Clin Ther2004，26，12： | 1 |
| 6 | Pharmacokinetic comparison of oral solution and tablet fomulations of citalopram:a single-dose,randomized,crossover study显示文摘 | Gutierrez MM Abramowitz W | 2000 | Clin Ther2000，22，： | 1 |
| 7 | An evaluation of the po- tential for pharmacokinetic interaction betwen escitalopram an d the cytochrome P450 3A4 inhibitor ritonavir显示文摘 | Gutierrez M Rosenberg J Abramowitz W | 2003 | Clin Ther2003，25，： | 1 |
| 8 | Pharmacokinetic comparison of oral solution and tablet formulations of citalopram: a single - dose, randomized, crossover study显示文摘 | Gutierrez MM Abramowitz W | 2000 | Clin Ther2000，22，： | 1 |
| 9 | Steady - state pharmacokinetics of citalopram in young and elderly subjects 显示文摘 | Gutierrez M Abramowitz W | 2000 | Pharmacotherapy2000，20，： | 1 |
| 10 | Pharmacokinetic comparison of oral solution and tablet formulations of citalopram:a single-dose,randomized,crossover study显示文摘 | GUTIERREZ MM ABRAMOWITZ W | 2000 | Clin Ther2000，22，12： | 1 |
| 11 | 'Nurses Don't Hate Change' :survey of nurses in a neonatal intensive care unit regarding the implementation,use and effectiveness of a bar code medication administration system显示文摘 | Morriss F H Jr Abramowitz P W Carmen L | 2009 | Healthc Q2009，12，： | 1 |
| 12 | An evaluation of the potential for pharmacokinetic interaction between escitalopram and the cytochrome P450 3A4 inhibitor ritonavir显示文摘 | Gutierrez M Rosenberg J Abramowitz W | 2003 | Clin Ther2003，25，3： | 1 |
| 13 | An evaluation of the potential for pharmacokinetic interaction between escitalopram and the cytochrome P450 3A4 inhibitor ritonavir显示文摘 | Gutierrez MM Rosenberg J Abramowitz W | 2003 | Clin Ther2003，25，4： | 1 |
| 14 | An evaluation of the potential for pharmacokinetic interaction between escitalopram and the cytochrome P450 3 A4 inhibitor ritonavir显示文摘 | Gutierrez MM Rosenberg J Abramowitz W | 2003 | Clin Ther2003，25，： | 1 |
| 15 | An evaluation of the potential for pharmacokinetic interaction between escitalopram and the cytochrome P450 3A4 inhibitor ritonavir显示文摘 | Gutierrez MM Rosenberg J Abramowitz W | 2003 | Clin Ther2003，25，： | 1 |
| 16 | Investigations of the exploding wire process as a source for high temperature studies显示文摘 | CASSIDY E C ABRAMOWITZ S BECKETT C W | 1980 | Nat Bur stand(U S) Monogr1980，25，： | 1 |
| 17 | Treatment of metabolic acidosis in patients with CKD 显示文摘 | Chen W Abramowitz MK | 2014 | Am J Kidney Dis2014，63，： | 1 |
| 18 | Lack of interaction between citalopram and the CYP3A4 substrate triazolam显示文摘 | Nolting A Abramowitz W | 2000 | Pharmacotherapy2000，20，： | 1 |
| 19 | Pharmacokinetic comparison of oral solution and tablet formulations of citalopram: a singledose, randomized, crossover study显示文摘 | Gutierrez MM Abramowitz W | 2000 | Clin Ther2000，22，12： | 1 |
| 20 | Treatment of metabolic acidosis in patients with CKD显示文摘 | Chen W Abramowitz MK | 2014 | Am J Kidney Dis2014，63，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员